The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.
Romero-Zerbo SY, García-Fernández M, Espinosa-Jiménez V, Pozo-Morales M, Escamilla-Sánchez A, Sánchez-Salido L, Lara E, Cobo-Vuilleumier N, Rafacho A, Olveira G, Rojo-Martínez G, Gauthier BR, González-Mariscal I, Bermúdez-Silva FJ.
Romero-Zerbo SY, et al. Among authors: sanchez salido l.
Front Endocrinol (Lausanne). 2020 Mar 6;11:103. doi: 10.3389/fendo.2020.00103. eCollection 2020.
Front Endocrinol (Lausanne). 2020.
PMID: 32210914
Free PMC article.